Home > M&A deals 2013 > Bay City Capital LLC invests in Conatus Pharmaceuticals, Inc.
PIPE · Life Science · July 2013

Bay City Capital LLC invests in Conatus Pharmaceuticals, Inc.

On July 25, 2013, Bay City Capital LLC invested in Conatus Pharmaceuticals, Inc., a life science company in California, United States, from Bay City Capital LLC and Gilde Healthcare Partners B.V.

Deal at a glance

AnnouncedJuly 25, 2013 TypePIPE TargetConatus Pharmaceuticals, Inc. Buyer Bay City Capital LLC Sellers Bay City Capital LLC
Gilde Healthcare Partners B.V. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Conatus Pharmaceuticals, Inc.
California, United States
Life Sciencesector
1991founded
Activestatus
View the company profile →

Buyer

Bay City Capital LLC
Private equity firm · 78 deals on record
  • 39th transaction in life science
  • 55th transaction in United States
78deals, all time
51in this sector
2013latest

Sellers (2)

Bay City Capital LLC
Private equity firm · 78 deals on record
Gilde Healthcare Partners B.V.
Private equity firm · 10 deals on record
78investments
51in this sector
53exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Conatus Pharmaceuticals, Inc.?Bay City Capital LLC invested in Conatus Pharmaceuticals, Inc. on July 25, 2013.

Who sold Conatus Pharmaceuticals, Inc.?Bay City Capital LLC and Gilde Healthcare Partners B.V. were the sellers.

What type of deal was it?It was a pipe in the life science sector in 2013.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).